headaches semaglutide Does Cause Headaches? Wegovy initiation may cut migraine

Current concepts of vagal efferent projections to the gut

Consequently, many uninsured or underinsured consumers struggle to sustain long-term treatment despite clinical need

Cumulative 36-month NAION incidence hit 8.9% in the diabetic semaglutide cohort versus 1.8% in comparators

Food noise and appetite are less affected by first-generation GLP-1s than by second-generation GLP-1s

Diarrhea The second most common side effect, affecting a higher percentage of participants at higher doses

Preliminary cardiovascular outcome data on tirzepatide in type 2 diabetes The above-mentioned preliminary cardiovascular safety data from the SURPASS-4 study demonstrated no excess cardiovascular risk associated with tirzepatide therapy (54, 73)